asof | 2025-02-17

Axsome Therapeutics, Inc. (NASDAQ:AXSM) is a biopharmaceutical company that
focuses on developing innovative treatments for central nervous system (CNS)
disorders. The company's pipeline includes promising therapies like AXS-05 for
major depressive disorder and Alzheimer's disease agitation, AXS-07 for
migraines, AXS-12 for narcolepsy, and AXS-14 for fibromyalgia. Axsome faces
competition in the CNS market but remains a key player due to its robust
pipeline.

